Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Prednisone in Acute Heart Failure With Elevated Inflammatory Markers
2022-001604-17Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisone in Acute Heart Failure (AHF), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in C-reactive protein level at day 7. Started Aug 2022; status: completed.
02
Drugs
prednisone
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2022-001604-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001604-17.